Gadicke Ansbert
SEC-identified person · CIK 1134655 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aktis Oncology, Inc. AKTS | Officer | filed 2026–2026 |
| Werewolf Therapeutics, Inc. HOWL | Officer | filed 2021–2025 |
| Iteos Therapeutics, Inc. ITOS | Director | filed 2020–2025 |
| Entrada Therapeutics, Inc. TRDA | Officer | filed 2021–2024 |
| TCR2 Therapeutics INC. TCRR | Director | filed 2019–2023 |
| Cullinan Therapeutics, Inc. CGEM | Director | filed 2021–2023 |
| Kalaris Therapeutics, Inc. KLRS | Director | filed 2020–2022 |
| Repare Therapeutics Inc. RPTX | Officer | filed 2020–2021 |
| Harpoon Therapeutics, Inc. HARP | Officer | filed 2019–2021 |
| Oncorus, Inc. ONCR | Officer | filed 2020–2020 |
| Dyne Therapeutics, Inc. DYN | Officer | filed 2020–2020 |
| Rhythm Pharmaceuticals, INC. SRYTM | Officer | filed 2017–2017 |
| Radius Health, Inc. RDUS | Director | filed 2008–2017 |
| Chiasma, INC CHMA | Director | filed 2015–2016 |
| Syndax Pharmaceuticals Inc SNDX | Officer | filed 2016–2016 |
| Cerecor Inc. CERC | Officer | filed 2015–2015 |
| Trivascular Technologies, Inc. TRIV | Officer | filed 2014–2014 |
| Aratana Therapeutics, INC. PETX | Officer | filed 2013–2014 |
| Epizyme, Inc. EPZM | Officer | filed 2013–2014 |
| Histogen Inc. HSTO | Officer | filed 2013–2013 |
| Pacira Pharmaceuticals, Inc. PCRX | Officer | filed 2011–2013 |
| Kalobios Pharmaceuticals INC KBIOQ | Officer | filed 2012–2013 |
| Somaxon Pharmaceuticals, Inc. somx | Officer | filed 2007–2012 |
| Verastem, Inc. VSTM | Director | filed 2012–2012 |
| Zalicus Inc. ZLCS | Officer | filed 2009–2011 |
| Reshape Weightloss Inc. etrm | Officer | filed 2007–2010 |
| Pharmathene, INC PIP | Officer | filed 2007–2010 |
| Aryx Therapeutics, Inc. ARYX | Officer | filed 2007–2010 |
| Senorx INC SENO | Officer | filed 2007–2010 |
| Aveo Pharmaceuticals, INC. AVEO | Officer | filed 2010–2010 |
| Metabasis Therapeutics INC MBRX | Officer | filed 2008–2010 |
| Peplin INC PLIN | Officer | filed 2008–2009 |
| Poniard Pharmaceuticals, INC. PARD | Officer | filed 2006–2009 |
| Oscient Pharmaceuticals Corp OSCI | Officer | filed 2009–2009 |
| Memory Pharmaceuticals Corp MEMY | Officer | filed 2006–2009 |
| Restore Medical, Inc. REST | Officer | filed 2006–2008 |
| Pharmasset Inc VRUS | Director | filed 2007–2008 |
| Cryocor INC CRYO | Officer | filed 2007–2008 |
| Viacell INC VIAC | Officer | filed 2007–2007 |
| Hemosense INC HEM | Officer | filed 2007–2007 |
| Ithaka Acquisition Corp ITHK.OB | Officer | filed 2007–2007 |
| Helicos Biosciences Corp HLCS | Officer | filed 2007–2007 |
| Critical Therapeutics INC CTRX | Officer | filed 2007–2007 |
| Cotherix INC CTRX | Officer | filed 2007–2007 |
| Affymax INC AFFY | Officer | filed 2006–2006 |
| Omrix Biopharmaceuticals, Inc. OMRI | Officer | filed 2006–2006 |
| Acorda Therapeutics, Inc. ACOR | Officer | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.